FIELD: medicine; pharmacology.
SUBSTANCE: invention refers to pharmacological composition for treatment of tumours containing derivative of acryloyldistamicine of formula (1) and inhibitor of protein kinase, product containing derivative of acryloyldistamicine of formula (1) and inhibitor of protein kinase, applied derivative of acryloyldistamicine of formula (1) and inhibitor of protein kinase within combined therapy for tumour treatment, as well as method of tumour treatment.
EFFECT: high efficiency of treatment.
27 cl, 4 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR APPLYING COMBINED ANTITUMOR THERAPY INCLUDING SUBSTITUTED ACRYLOYL DISTACMYCIN DERIVATIVES USAGE AND RADIATION THERAPY | 2003 |
|
RU2314807C2 |
| COMPOUNDS AND METHODS FOR KINASE MODULATION AND INDICATIONS FOR THEIR USE | 2013 |
|
RU2666146C2 |
| COMBINATION, INCLUDING A) PYRIMIDYLAMINOBENZAMIDE AND B) KINASE Thr315lle INHIBITOR | 2007 |
|
RU2481840C2 |
| COMBINATIONS CONTAININS Bcr-Abl/c-Kit/PDGF-RTK INHIBITORS FOR TREATING CANCER | 2007 |
|
RU2452492C2 |
| COMBINATIONS OF THERAPEUTIC AGENTS FOR CANCER TREATMENT | 2007 |
|
RU2449788C2 |
| HETEROCYCLIC COMPOUNDS AND THEIR APPLICATION | 2016 |
|
RU2744897C2 |
| COMBINATIONS OF THERAPEUTIC AGENTS APPLICABLE FOR TREATING CANCER | 2007 |
|
RU2447891C2 |
| CHROMENONE COMPOUNDS AS PI3-KINASE INHIBITORS FOR TREATING CANCER | 2012 |
|
RU2598028C2 |
| COMPOUNDS USED AS ATR KINASE INHIBITORS | 2013 |
|
RU2689996C2 |
| ACRYLOYL-SUBSTITUTED PYRROLE DERIVATIVES AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, PHARMACEUTICAL COMPOSITION BASED THEREON, AND METHOD OF PREPARATION THEREOF | 1990 |
|
RU2094430C1 |
